Efficacy of abatacept or infliximab treatment in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a 1-year double-blind, randomized, placebo-controlled trial

被引：0

作者：

Bessette, L. ^{[1
]}

Homik, J. ^{[2
]}

Dougados, M. ^{[3
]}

Keiserman, M. ^{[4
]}

Codding, C. ^{[5
]}

Songcharoen, S.

Berman, A. ^{[6
]}

Nayiager, S. ^{[7
]}

Saldate, C. ^{[8
]}

Aranda, R. ^{[9
]}

Becker, J. ^{[9
]}

Li, T. ^{[9
]}

Lin, C. ^{[10
]}

Cornet, P. L. N. ^{[11
]}

Schiff, M. ^{[12
]}

机构：

[1] Univ Quebec, Ctr Hosp, Ste Foy, PQ G1V 2M3, Canada

[2] Univ Alberta, Edmonton, AB, Canada

[3] Hop Cochin, F-75674 Paris, France

[4] Pontificia Univ Catolica, Sch Med, Porto Alegre, RS, Brazil

[5] Hlth Res Oklahoma, Oklahoma City, OK USA

[6] Ctr Med Privade Reumatol, San Miguel De Tucuman, Argentina

[7] St Augustines Med Ctr, Durban, South Africa

[8] Ctr Investigac Noroeste, Tijuana, Mexico

[9] Bristol Myers Squibb Co, Princeton, NJ USA

[10] Bristol Myers Squibb Co, Hopewell Jct, NY USA

[11] Bristol Myers Squibb Co, Shanghai, Peoples R China

[12] Denver Arthritis Clin, Denver, CO USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1178 / 1179

页数：2